BioCentury
BioCentury
ARTICLE | Product Development

Macrophage therapies to watch at AACR

BioCentury analyzes strategies targeting macrophages at AACR21

By Lauren Martz, Senior Editor
April 9, 2021 1:31 AM UTC


Access this Article
Request a Trial
Purchase This Article
Log in

BCIQ Company Profiles

Carisma Therapeutics Inc.

Pionyr Immunotherapeutics Inc.

Jounce Therapeutics Inc.

Pathios Therapeutics Ltd.

BCIQ Company Profiles

Carisma Therapeutics Inc.

Pionyr Immunotherapeutics Inc.

Jounce Therapeutics Inc.

Pathios Therapeutics Ltd.

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Cookie Policy
California Privacy Rights
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
LinkedIn
Twitter
RSS
BioCentury
© 2022 BioCentury Inc. All Rights Reserved.
Copyright © 2022 BioCentury Inc. All Rights Reserved.
LinkedIn
Twitter
RSS